소화성궤양 환자의 의료이용행태

배승진 건강보험심사평가원 심사평가연구소 2011 HIRA 정책동향 Vol.5 No.3

임상적 유용성 및 비용효과성을 고려한 급여 결정 사례 비교 : 한국, 호주, 캐나다

배승진 한국보건사회약료경영학회 2012 한국보건사회약료경영학회 학술대회 Vol.2012 No.1

전기압력밥솥의 안전관리

배승진,Bae, Seung-Jin 기술표준원 2006 기술표준 Vol.49 No.-

미국의 의료 전산 지원제도 고찰

배승진 건강보험심사평가원 심사평가연구소 2009 HIRA 정책동향 Vol.3 No.3

부산 초대해관장(初代海關長) 로바트와 조선해관에 관한 몇가지 부언(附言)

배승진 ( Sung Zin Bae ) 한국국제무역학회 2004 國際貿易硏究 = Journal of international trade studies Vol.10 No.1

본고는 김재승 著 釜山海關 開廳과 初代海關長 W. N. Lovatt에 나오는 몇가지 문제점을 지적하고자 한다. 그의 논문에서 著者는 새로이 발굴된 로바트 私文書를 이용하여 지금까지 日帝의 記述을 무작정 따라 1883년 11월 3일이라고 여겨왔던 부산해관 개청일자가 실제로는 同年 7윌 3일임을 보이려 하고 있다. 그런데 저자는 목적하는 바의 正當性에도 불구하고, 證漂 과정에서 史料調査의 불충분함 때문에 필연적으로 야기되는 原文解驛의 錯誤와 그에 따른 論理展開의 誤謬를 범하고 있다. 가장 정확한 예를 들자면 釜山 初代海關長의 漢文 이름은 魯富이지 저자가 주장하듯 魯外械는 아니다. 이와 같은 基礎的인 잘못은 저자의 論文에서뿐만 아니라 開港期의 韓國史 특히 貿易史 및 海關史 관련 연구들에서 종종 볼 수 있는 것들이다. 그 이유로는 무엇보다 國際的 政治經濟 그리고 外交問題를 광범하게 다루어야 하는 근대경제사에 海外史料가 절대적으로 부족함을 들 수 있겠으며, 그러한 기본 사료를 꾸준히 찾아서 정리하려는 召命感의 제고와 그에 걸맞은 支援만이 韓國近代史 연구의 발전을 기할 수 있는 關鐘임을 본고는 다시 한번 강조하고자 한다. Mr. Jae-Seung Kim (김재승) recently published a paper entitled Opening of [the] Busan Customs and [its] first Commissioner, William Nelson Lovatt in Studies in International Trade (國際貿易硏究, Vol. 9 No. 2, Oct. 2003, pp. 1-32 in Korean.) Of highly historical interest, it does merit some further remarks. The author is, as well as I know, one of those rare scholars who excel in biographical approaches to the study of Korean history. Such methods are becoming popular among the historians suffering from the lack of reliable materials, especially among those of Korea, the land of incessant wars and economic transformations destroying (if not negating) her past. Collection of biographical data requires genealogical inquiry. Not only is this the first and most important step, but it is also a long and fastidious investigation imposed to us when tracing each and every descendant or relative of the person we study. For the vast majority of men and women who had no privilege of need more precision. seeing their biography published, the public archives such as census, birth, marriage and death records remain the only proof of their historical existence. Yet identifying a person among millions of million records with a simple knowledge of his or her family name rather belongs to chance itself. Looking for a sear sheet of paper in private archives resorts to a treasure hunting. But treasuring what has been found etemises the pains of Sisyphus. Scholars who explore those archives are therefore obliged to give, first of all, complete descriptions of their primary sources that will guide subsequent studies. Otherwise there is no discussion between historians about same things, no open knowledge thence, only fragmented and redundant fanfares of discoverer that replay some years later in ignoring what has been done before. In this respect, the evidences presented in Mr. Kim`s paper

Further remarks on William Nelson Lovatt(魯富), and the Korean Maritime Customs

Bae, Sung-zin 국제무역학회 2004 국제무역연구 Vol.10 No.1

본고는 김재승 著 "釜山海關 開廳과 初代海關長 W. N. Lovatt"에 나오는 몇가지 문제점을 지적하고자 한다. 그의 논문에서 著者는 새로이 발굴된 로바트 私文書를 이용하여 지금까지 日帝의 記述을 무작정 따라 1883년 11월 3일이라고 여겨왔던 부산해관 개청일자가 실제로는 同年 7윌 3일임을 보이려 하고 있다. 그런데 저자는 목적하는 바의 正當性에도 불구하고, 證漂 과정에서 史料調査의 불충분함 때문에 필연적으로 야기되는 原文解驛의 錯誤와 그에 따른 論理展開의 誤謬를 범하고 있다. 가장 정확한 예를 들자면 釜山 初代海關長의 漢文 이름은 魯富이지 저자가 주장하듯 魯外械는 아니다. 이와 같은 基礎的인 잘못은 저자의 論文에서뿐만 아니라 開港期의 韓國史 특히 貿易史 및 海關史 관련 연구들에서 종종 볼 수 있는 것들이다. 그 이유로는 무엇보다 國際的 政治經濟 그리고 外交問題를 광범하게 다루어야 하는 근대경제사에 海外史料가 절대적으로 부족함을 들 수 있겠으며, 그러한 기본 사료를 꾸준히 찾아서 정리하려는 召命感의 제고와 그에 걸맞은 支援만이 韓國近代史 연구의 발전을 기할 수 있는 關鐘임을 본고는 다시 한번 강조하고자 한다. Mr. Jae-Seung Kim (김재승) recently published a paper entitled "Opening of [the] Busan Customs and [its] first Commissioner, William Nelson Lovatt" in Studies in International Trade (國際貿易硏究, Vol. 9 No. 2, Oct. 2003, pp. 1-32 in Korean.) Of highly historical interest, it does merit some further remarks. The author is, as well as I know, one of those rare scholars who excel in biographical approaches to the study of Korean history. Such methods are becoming popular among the historians suffering from the lack of reliable materials, especially among those of Korea, the land of incessant wars and economic transformations destroying (if not negating) her past. Collection of biographical data requires genealogical inquiry. Not only is this the first and most important step, but it is also a long and fastidious investigation imposed to us when tracing each and every descendant or relative of the person we study. For the vast majority of men and women who had no privilege of need more precision. seeing their biography published, the public archives such as census, birth, marriage and death records remain the only proof of their historical existence. Yet identifying a person among millions of million records with a simple knowledge of his or her family name rather belongs to chance itself. Looking for a sear sheet of paper in private archives resorts to a treasure hunting. But treasuring what has been found etemises the pains of Sisyphus. Scholars who explore those archives are therefore obliged to give, first of all, complete descriptions of their primary sources that will guide subsequent studies. Otherwise there is no discussion between historians about same things, no open knowledge thence, only fragmented and redundant fanfares of discoverer that replay some years later in ignoring what has been done before. In this respect, the evidences presented in Mr. Kim's paper

Analysis of Statistical Methods Currently used in Toxicology Journals

나지혜,배승진,임경민,양혜리 한국독성학회 2014 Toxicological Research Vol.30 No.3

Statistical methods are frequently used in toxicology, yet it is not clear whether the methods employed by the studies are used consistently and conducted based on sound statistical grounds. The purpose of this paper is to describe statistical methods used in top toxicology journals. More specifically, we sampled 30 papers published in 2014 from Toxicology and Applied Pharmacology, Archives of Toxicology, and Toxicological Science and described methodologies used to provide descriptive and inferential statistics. One hundred thirteen endpoints were observed in those 30 papers, and most studies had sample size less than 10, with the median and the mode being 6 and 3 & 6, respectively. Mean (105/113, 93%) was dominantly used to measure central tendency, and standard error of the mean (64/113, 57%) and standard deviation (39/113, 34%) were used to measure dispersion, while few studies provide justifications regarding why the methods being selected. Inferential statistics were frequently conducted (93/113, 82%), with one-way ANOVA being most popular (52/93, 56%), yet few studies conducted either normality or equal variance test. These results suggest that more consistent and appropriate use of statistical method is necessary which may enhance the role of toxicology in public health.

클라우드 환경에서의 Log4J 취약점 영향 분석을 통한 Log4J 취약점 스캐닝 시스템 연구

장수원,배승진,이세한,박기웅 한국차세대컴퓨팅학회 2022 한국차세대컴퓨팅학회 학술대회 Vol.2022 No.05

현재 클라우드 서비스는 다양한 분야에서 활용되고 있으며, 특히 서버 구축에 필요한 인프라(물리적 스토리지, 물리적 서버 등)를 가상화된 서비스 형태로 제공하는 IaaS(Infrastructure as a Service)와 IaaS로 제공되어 인프라 위에 사용자가 원하는 서비스를 개발할 수 있는 PaaS(Platform as a Service)가 주로 이용되고 있다. 그러나 이러한 클라우드 서비스를 이용하는 사용자가 구축한 가상화 환경의 다양한 서비스에서 Log4j 관련 취약점이 발생되어 많은 피해가 발생하고 있으며, 현재까지 심각한 위협으로 여겨지고 있다. 이에 본 논문에서는 클라우드 서비스를 활용한 사용자 정의 서비스를 구축 시, Log4j 취약점의 영향을 분석하여 향후 유사한 취약점으로부터 대응할 수 있도록 도움을 주고자 한다.

주요 외국의 의약품 위험분담제도에 대한 고찰: 계약현황과 사후관리방안을 중심으로

이영실,배승진,이보람,손경복,최현진,배은영,장수현,이태진 한국보건의료기술평가학회 2017 보건의료기술평가 Vol.5 No.1

This study was carried out to investigate the current situation of risk sharing arrangements (RSA) in other countries, mainly focusing on types of contracts and management system, in order to suggest helpful implications for Korean RSA system. United Kingdom (UK), Australia, Italy, Germany were selected considering their similarity with the Korean system and the availability of data. We searched for existing researches, guidelines, reports, and related webpages using PubMed, Google, and relat- ed websites for each country. UK’s RSA is referred to as patient access scheme (PAS). It is included in NICE’s recommendation and does not have specific criteria for application. It uses simple discount schemes more than complex schemes. PAS is evaluated alongside the NICE’s recommendation. Aus- tralian RSA consists of RSA for financial risk and the managed entry scheme (MES) for clinical uncer- tainty. There are no specific criteria in the application for RSA. But the application for MES requires high clinical needs and subsequent clinical trial. Most of contracts are financial-based schemes. Deci- sion about the renewal of contracts is based on the market situation and the newly introduced man- aged access programme (MAP) requires pharmaceutical companies to provide information about potential cancellation of reimbursement and to obtain patient’s consent. Italian RSA is referred to as managed entry agreements. It also does not include specific criteria in the application but has unique national level web-registry. Unusually, Italy uses outcome-based schemes substantially. Germany has unique mandatory rebate system. Overall, there were considerable differences between those countries we examined and Korea. But Australian MAP shed some light on the management of RSA in Korea.

흡입스테로이드제와 흡입지속성베타작용제의 복합제 사용에서 폐렴 발생위험비교를 위한 코호트 연구

박지혜,신주영,배승진 한국보건의료기술평가학회 2017 보건의료기술평가 Vol.5 No.2

Objectives: The purpose of this study is to compare the risk of hospitalization by pneumonia between two different inhaled corticosteroid (ICS)/long-acting beta2-agonist (LABA) substances. Methods: Retrospective cohort study was conducted using 2013 National Patients Sample of Health Insurance Review and Assessment Service (HIRA-NPS) database. The cohort consisted of the patients who are prescribed dry powder inhaler form of fluticasone/salmeterol and budesonide/formoterol at least once (28 days) from Feb 2013 to Dec 2013 and who had no record of prescription of ICS/LABA one month prior to the index date. The patients who were enrolled to the cohort was observed until the first hospitalization due to pneumonia (J12-18 of International Classification of Diseases-10 code) occurrence. The incidence rate of pneumonia were estimated and crude and adjusted hazard ratio of pneumonia associated with ICS/LABA use with 95% CIs were estimated by Cox regression model. Results: The cohort included 5597 patients of which 4274 patients (76.4%) treated with fluticasone/salmeterol and 1323 patients (23.6%) treated with budesonide/formoterol. The pneumonia incidence rate was higher with fluticasone/salmeterol which was 8.16 per 100 person-year while the pneumonia incidence rate of budesonide/formoterol was 5.04 per 100 person-year. Compared with budesonide/formoterol, the pneumonia risk was higher in patients treated with fluticasone/salmeterol (hazard ratio: 1.46, 95% CI: 1.04−2.04). Conclusion: The higher risk of pneumonia occurrence was observed for fluticasone/salmeterol which shows the intra-class difference of fixed combination of inhaled corticosteroid/long acting beta-2 agonist.